CDK7 and neoplasm: 1. Chemotherapy + ICB improves progression-free survival in patients [58,59,61,62]2. Chemotherapy + OV improved therapeutic efficacy [63,64,65]3. Chemotherapy + cell-based therapies [66,67,68]4. ACT + OVV + HDACi reprogrammed immunosuppressive myeloid cells, eliminating antigen-negative tumor cells in mice [60]5. CDK7 + ICB enhanced antitumor immunity and prolonged survival outcomes in mice [69]